AMERICAN STRATEGIC INVESTM-A (NYC) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NYC - US6494393043 - Common Stock
10.22 USD
+0.34 (+3.44%)
10.22 USD
0 (0%)
NYC gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. NYC has a bad profitability rating. Also its financial health evaluation is rather negative. NYC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- NYC had negative earnings in the past year.
- NYC had a negative operating cash flow in the past year.
- In the past 5 years NYC always reported negative net income.
- In the past 5 years NYC always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of NYC (-4.72%) is worse than 63.49% of its industry peers.
- Looking at the Return On Equity, with a value of -29.63%, NYC is doing worse than 68.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.72% | ||
| ROE | -29.63% | ||
| ROIC | N/A |
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of NYC (24.71%) is comparable to the rest of the industry.
- NYC's Gross Margin has declined in the last couple of years.
- NYC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.71% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
2. Health
2.1 Basic Checks
- NYC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NYC has more shares outstanding
- Compared to 5 years ago, NYC has more shares outstanding
- NYC has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -1.99, we must say that NYC is in the distress zone and has some risk of bankruptcy.
- NYC has a Altman-Z score of -1.99. This is amonst the worse of the industry: NYC underperforms 82.54% of its industry peers.
- NYC has a Debt/Equity ratio of 4.88. This is a high value indicating a heavy dependency on external financing.
- NYC has a Debt to Equity ratio of 4.88. This is amonst the worse of the industry: NYC underperforms 84.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.88 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.99 |
ROIC/WACCN/A
WACC4.74%
2.3 Liquidity
- A Current Ratio of 0.91 indicates that NYC may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.91, NYC is doing worse than 77.78% of the companies in the same industry.
- NYC has a Quick Ratio of 0.91. This is a bad value and indicates that NYC is not financially healthy enough and could expect problems in meeting its short term obligations.
- NYC has a Quick ratio of 0.91. This is in the lower half of the industry: NYC underperforms 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
- NYC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.73%, which is quite impressive.
- NYC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.71%.
- NYC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.68% yearly.
EPS 1Y (TTM)89.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-20.58%
3.2 Future
- The Earnings Per Share is expected to grow by 0.45% on average over the next years.
- The Revenue is expected to grow by 2.40% on average over the next years.
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for NYC. In the last year negative earnings were reported.
- Also next year NYC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYC is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 139.95 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.45%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for NYC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
10.22
+0.34 (+3.44%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-19 2025-11-19/amc
Earnings (Next)03-17 2026-03-17
Inst Owners2.23%
Inst Owner Change0%
Ins Owners5.41%
Ins Owner Change10.25%
Market Cap27.29M
Revenue(TTM)51.69M
Net Income(TTM)-21.15M
Analysts45
Price TargetN/A
Short Float %0.06%
Short Ratio0.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.53 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.38 | ||
| P/tB | 0.38 | ||
| EV/EBITDA | 139.95 |
EPS(TTM)-25.61
EYN/A
EPS(NY)-12.33
Fwd EYN/A
FCF(TTM)-4.93
FCFYN/A
OCF(TTM)-4.52
OCFYN/A
SpS19.36
BVpS26.73
TBVpS26.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.72% | ||
| ROE | -29.63% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.71% | ||
| FCFM | N/A |
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.88 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 131.27 | ||
| Cap/Depr | 7.89% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | -1.99 |
F-Score4
WACC4.74%
ROIC/WACCN/A
Cap/Depr(3y)13.9%
Cap/Depr(5y)12.89%
Cap/Sales(3y)5.75%
Cap/Sales(5y)5.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
EPS Next Y2.11%
EPS Next 2Y0.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.71%
Revenue growth 3Y-4.29%
Revenue growth 5Y-2.68%
Sales Q2Q%-20.58%
Revenue Next Year3.18%
Revenue Next 2Y2.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.48%
OCF growth 3YN/A
OCF growth 5YN/A
AMERICAN STRATEGIC INVESTM-A / NYC FAQ
What is the ChartMill fundamental rating of AMERICAN STRATEGIC INVESTM-A (NYC) stock?
ChartMill assigns a fundamental rating of 0 / 10 to NYC.
What is the valuation status of AMERICAN STRATEGIC INVESTM-A (NYC) stock?
ChartMill assigns a valuation rating of 0 / 10 to AMERICAN STRATEGIC INVESTM-A (NYC). This can be considered as Overvalued.
Can you provide the profitability details for AMERICAN STRATEGIC INVESTM-A?
AMERICAN STRATEGIC INVESTM-A (NYC) has a profitability rating of 0 / 10.
Can you provide the financial health for NYC stock?
The financial health rating of AMERICAN STRATEGIC INVESTM-A (NYC) is 0 / 10.
What is the earnings growth outlook for AMERICAN STRATEGIC INVESTM-A?
The Earnings per Share (EPS) of AMERICAN STRATEGIC INVESTM-A (NYC) is expected to grow by 2.11% in the next year.